Objective-To investigate the central and peripheral haemodynamic response to dobutamine stress testing in women with suspected ischaemic heart disease and to seek an explanation for the hypotension phenomenon. Design-18 women aged 54-73 years were investigated with Doppler echocardiography and venous occlusion plethysmography during intravenous infusion of dobutamine 5-10 d after an episode of unstable angina. Results-An average peak dose of 33 (SD 9.7) ug/kg/min was given. Heart rate and cardiac output increased by 49% and 59%, respectively (P < 0.001). Total Postsynaptic a, and P2 receptors of peripheral vessels mediate vasoconstriction and vasodilatation respectively. Dobutamine infusion leads to a complex haemodynamic alteration since it directly stimulates the adrenoreceptors of the heart and the vascular bed but also indirectly acts on the cardiovascular system through reflex inhibition of sympathetic tone and vasovagal reactions. In a previous study we investigated the haemodynamic response to dobutamine in healthy women and found a marked increase in heart rate and cardiac output and a marked decrease in peripheral vascular resistance.7 The cardiovascular response was dose and age dependent and hypotension was uncommon. However, studies in patients are lacking. 
peripheral vascular resistance decreased by 44% and 26%, respectively (P < 0.001).
Four patients developed hypotension (decrease in systolic blood pressure > 10 mm Hg), one of whom had a paradoxical bradycardia and two a low increase in cardiac output. Patients with hypotension had a more pronounced decrease in total peripheral vascular resistance but a similar change in leg peripheral vascular resistance compared with patients without hypotension. Conclusions-Dobutamine infusion leads to marked peripheral vasodilatation and an increase in cardiac output. Some patients experience hypotension during the test for reasons which include paradoxical vasovagal reactions and diminished capacity for adequate increase in cardiac output. There is also a disparity between the pattern of total and leg peripheral vascular resistance in patients with hypotension which might reflect a baroreceptor mediated compensatory increase in vasoconstrictor tone of muscle vessels not matched in other vascular territories.
Dobutamine stress echocardiography has been used with increasing frequency as a method for detecting coronary artery disease.12 Some groups have reported a fall in systolic blood pressure during the test.3-5 Whereas exercise induced hypotension has been recognised as an indicator of severe coronary artery disease, 6 hypotension during dobutamine stress testing is not associated with advanced coronary disease or an adverse prognosis. 4 The cause of hypotension is unclear, but myocardial ischaemia, valvar obstructive disease, obstructive cardiomyopathy, and vasovagal reflexes have been mentioned as possible mechanisms.35 Furthermore, an increased incidence of hypotension has been reported in older patients, women, and patients not on ,B blockers.5 Dobutamine is a synthetic catecholamine which stimulates postsynaptic a and ,B receptors of the cardiovascular system. The predominant postsynaptic adrenoreceptor of the heart is of the f3 subtype which mediates a positive inotropic and chronotropic effect.
Postsynaptic a, and P2 receptors of peripheral vessels mediate vasoconstriction and vasodilatation respectively. Dobutamine infusion leads to a complex haemodynamic alteration since it directly stimulates the adrenoreceptors of the heart and the vascular bed but also indirectly acts on the cardiovascular system through reflex inhibition of sympathetic tone and vasovagal reactions. In a previous study we investigated the haemodynamic response to dobutamine in healthy women and found a marked increase in heart rate and cardiac output and a marked decrease in peripheral vascular resistance.7 The cardiovascular response was dose and age dependent and hypotension was uncommon. However, studies in patients are lacking.
The aim of our present study was to investigate the central and peripheral haemodynamic alterations during dobutamine stress testing with blood pressure measurement, Doppler, echocardiography, and venous occlusion plethysmography in a group of women with objective signs of coronary artery disease. Doppler device (Vingmed CFM 800, Vingmed Sound). The recordings were stored on video tapes, optical discs, and paper printouts. The electrocardiographic chest electrodes were positioned so as not to cover the marked site for the echo acoustic window. Stroke volume was determined as the product of the subaortic flow area and the temporal velocity profile in the left ventricular outflow tract.9 The subvalvar aortic diameter was measured in the parastemal long axis view before the infusion and at peak dose of dobutamine and calculated as the mean of two measurements. The flow velocity was measured with pulsed wave Doppler with the sample volume placed in the middle of the left ventricular outflow tract in the apical five chamber view at rest and at peak dose dobutamine and calculated as mean of three measurements. The coefficient of variation in measuring the subaortic area is 4% at our department.'0 The interobserver variability in determination of subvalvar flow velocity integral is 2-4 (SD 1-5)%.9 Cardiac output was derived using the formula: left ventricular outflow tract cross sectional area x flow velocity integral x heart rate. Total peripheral vascular resistance was calculated as mean arterial blood pressure divided by cardiac output.
Patients
The cross sectional recordings were analysed independently by two observers, having several years of experience with stress echocardiography. The left ventricle was divided into 16 segments for analysis and the wall motion of each segment was classified according to a six grade scale: 0 = not visualised, 1 = normal, 2 = hypokinesia, 3 = akinesia, 4 = dyskinesia, and 5 = aneurysm. 8 Echocardiograms were interpreted without knowledge of clinical data or coronary angiographic findings. When there was a disagreement about the result, the two observers together reviewed the study and reached a consensus on the grading. The interobserver agreement with regard to segmental analysis was 83%. A wall motion index was derived representing the sum of all scores divided by the number of segments visualised in each patient.
VENOUS OCCLUSION PLETHYSMOGRAPHY
Plethysmographic recordings were obtained from the right leg with the subjects lying on the left side. The right leg was slightly elevated, supported with pillows at knee and ankle level and raised approximately 100 above the horizontal level. A mercury-in-silastic strain gauge plethysmograph (Medimatic SP2) was used with a thin tubing placed around the right calf where the circumference was largest. An 8 cm wide blood pressure cuff was applied on the distal part of the thigh, proximal to the knee, and the venous outflow from the calf was occluded with a pressure of 80 mm Hg for a period of 10 s. During venous occlusion, the arterial flow into the calf produced swelling of the leg, stretching of the gauge, and increased electrical resistance proportional to the increase in calf volume. From changes of calf circumference per unit time, muscle blood flow can be calculated and expressed as ml/min/litre tissue."I Recordings were obtained three to five times at rest and three times at peak dose dobutamine infusion. The coefficient of variation in leg flow measurement was 16%. Peripheral leg blood flow resistance was calculated as mean arterial pressure divided by The heart rate increased from 61 (8) beats/ min at rest to 91 (13) at peak dose dobutamine (P < 0-001) (table 1) . Systolic blood pressure in the group as a whole was unchanged but diastolic blood pressure decreased from 69 (9) mm Hg at rest to 53 (18) mm Hg at peak dose (P < 0-001). There was no significant change in stroke volume: 70 (13) ml before the infusion and 75 (15) ml at peak dose of dobutamine. However, because of the increase in heart rate (61-91 beats/min), cardiac output increased from 4-2 (0 8) litres/min at rest to 6-7 (1-5) at peak dose (P < 0-001 (14) beats/min] (P < 0.1), and a tendency towards a decrease in systolic blood pressure [-11 (27) 
HYPOTENSION
Four patients showed hypotension, define drop in systolic blood pressure of > 10 m on two subsequent recordings at peak dobutamine compared with rest (table 2' The first woman was obese. She had motion index of 1 25 and no new wall n abnormalities during the test. Coi angiography showed three vessel diseas she was treated with a /,3 blocking agent, cium antagonist, long acting nitrates diuretics. She received a peak do 40 ,ug/kg/min but had a very low incre heart rate (+ 5 beats/min) and cardiac c (+ 0-7 litres/min) despite a reduced peripheral vascular resistance of 46%.
The second patient had normal coI angiography, normal wall motion at res no signs of ischaemia during dobutamint sion. Her change in heart rate, cardiac o and peripheral vascular resistance did not from the other patients. Comparison of heart rate, cardiac output, maximum systolic bloodflow velocity in t, ventricular outflow tract (peakflow velocity), and bloodflow in the right leg (legflc 18 patients from the present study and 11 healthy middle aged women.7 Data are m bars = SD, at the preinfusion level (rest) and at peak dose dobutamine (peak doseã lterations during dobutamine infusion were less pronounced in the patients than in the healthy subjects (P < 0 05). The third woman had severe left ventricular systolic dysfunction with a wall motion index of 1 87 at rest, but only one vessel disease on coronary angiography. She received a peak dose of 30,g/kg/min, developed new wall motion abnormalities, and had a very low increase in cardiac output of + 0 5 litre/min.
The fourth patient had impaired left ventricular function, a wall motion index of 1-56 at rest, and two vessel disease including a proximal obstruction on the left anterior descending coronary artery. She received a peak dobutamine dose of 40 pg/kg/min and developed new wall motion abnormalities and a paradoxical decrease in heart rate from 103 beats/min to 76 beats/min at peak dose, just before the infusion was stopped.
These four patients had a more pronounced decrease in total peripheral vascular resistance, -14-9 (4-4) mm Hg/litre/min, compared with -9 3 (3 9) mm Hg/litre/min in the other patients (P < 0 05). Conversely, leg blood flow tended to decrease during dobutamine infusion in the hypotension group, at -2-8 (3 5) ml/min/litre tissue compared with an increase of + 4-8 (4 8) in the other patients (P < 0 01), and there was no difference in leg peripheral vascular resistance between the groups.
,se ot COMPARISON WITH HEALTHY WOMEN ase in In a previous study we investigated the haemo-)utput dynamic response to dobutamine in 11 healthy total women of comparable age to the patients in the present study.7 The patients in our present ronary study received a higher peak dose of dobuta-,t, and mine, 33 (9 7) gg/kg/min compared with 22 e infu-(7.5) ug/kg/min in the normal subjects (P < utput, 0 01), but heart rate, maximum systolic blood t differ flow velocity in the left ventricle outflow tract, cardiac output, and leg blood flow increased less in the patients compared with the healthy subjects (table 3) (figure). There was no difference in change of vascular resistance between the groups. Hypotension was seen in four out of 18 patients in the present study compared with one of 11 normal subjects.
Discussion
Hypotension was common in the present study (22%) and of the same magnitude as reported in another recent study (20%) of Marcovitz et al. 5 Rosamond et al4 found a hypotensive response in as many as 38% compared with only 9% in a study of healthy subjects previously published. However, the difference in the numbers of patients developing hypotension between these four studies is not significant. group.bmj.com on April 13, 2017 -Published by http://heart.bmj.com/ Downloaded from inotropic and chronotropic effects on the heart. Non-selective ,B blockers also negate the /2 mediated vasodilatation. This is probably the reason why hypotension is less common in patients with blocker treatment and why our patients had a lower increase in heart rate and cardiac output compared with the healthy subjects, despite the fact that they received a higher peak dose of dobutamine. 7 Elderly patients have diminished cardiovascular reflex responses and a reduced capacity to compensate adequately for changes in blood pressure, vascular resistance, and capacitance, and this might explain why hypotension is more common in them. ' Left ventricular function, as expressed by wall motion index, improved in most patients and this may appear paradoxical but can be explained on the basis of recruitment of areas with stunned or hibernated myocardium during dobutamine stimulation. It has been shown that the addition of atropine at peak dose dobutamine enhances the sensitivity of dobutamine stress echocardiography and it would probably have increased the number of patients with new or worsening of wall motion abnormalities in our study. '4 Pellikka et al proposed that cavity obliteration was common in patients with a good left ventricular function and, in combination with mild dehydration, might be the cause of hypotension in patients with a very hyperkinetic left ventricle and without significant coronary artery disease.' This is in line with our results; two healthy women developed an outflow obstruction in our previous study but no cavity obliteration was seen in the present study .7 It has been suggested that hypotension might be caused by the vasodilating effects of dobutamine.' Dobutamine has a direct effect on arterial and venous tone, and also an indirect effect through reflectory withdrawal of sympathetic vasoconstrictor tone secondary to the increase in cardiac output.15 16 A decrease in systemic vascular resistance of 30-40% during dobutamine infusion has been reported in patients.1 In the present study we found a decrease of 44% in total peripheral vascular resistance and 26% in leg peripheral vascular resistance. We found a more pronounced decrease in total peripheral vascular resistance in patients with hypotension compared with those without hypotension. Furthermore, in the hypotensive patients we noted a disparity between the pattern of total and leg peripheral vascular resistance. While total peripheral vascular resistance declined markedly, there was a decline in leg blood flow, consistent with vasoconstriction in muscle vessels. This reaction obviously reflects a baroreceptor mediated compensatory reaction not matched by reduction in other vascular territories. '7 One patient in the present study (AN-18) developed a paradoxical bradycardia and a decrease in blood pressure at peak dose dobutamine. Exogenous catecholamine infusion during upright tilt testing has been used to elicit vasovagal reactions with symptomatic hypotension and bradycardia in patients with recurrent syncope of unknown origin.'8 Mazeika et al found a paradoxical hypotension-bradycardia in seven of 50 patients undergoing dobutamine echocardiography."9 Vasovagal reactions could therefore be one explanation for the hypotension.
LIMITATIONS OF THE STUDY
Calculating mean arterial blood pressure as diastolic pressure + one third of the pulse pressure might underestimate the mean arterial blood pressure when heart rate and pulse pressure increases during dobutamine infusion. This could result in an overestimation of the decrease in peripheral vascular resistance. However, the change in pulse pressure was rather low compared to changes in flow so this possible error is of minor importance. Invasive blood pressure and cardiac output measurements would have been of advantage but were deemed unethical to use. Medical treatment could not be standardised because of different needs and contraindications in different patients. Withdrawal of antianginal treatment before a stress test is considered unethical in this group of patients in Sweden. CONCLUSIONS Dobutamine stress testing causes marked peripheral vasodilatation and increased cardiac output, but the changes are blunted in patients on ,B blockers compared with healthy subjects. Hypotension is a common side effect of dobutamine in investigations on patients, the cause of which is probably multifactorial, including paradoxical vasovagal reactions and diminished capability to increase cardiac output adequately. Furthermore, there is a disparity between the pattern of total and leg peripheral vascular resistance in patients with hypotension which might reflect a baroreceptor mediated compensatory increase in vasoconstrictor tone of muscle vessels not matched in other vascular territories. This is the first study which provides a detailed central and peripheral haemodynamic analysis of the dobutamine stress test in women with coronary artery disease.
